Ranjit Manchanda, Co-Lead of Screening Prevention and Epidemiology Unit, Wolfson Institute of Population Health at Queen Mary University of London, shared a post on LinkedIn:
“Delighted to see our DETECT-2 Protocol paper published.
“Direct to Patient Testing at Cancer Diagnosis for Precision Prevention-2 (DETECT-2): protocol for a two-arm equivalence UK multi-centre randomised controlled trial evaluating uptake of genetic testing”
Huge thank you to the entire team, all stakeholders and collaborators as well as funding organisations for their support of this important trial.”
Title: Direct to Patient Testing at Cancer Diagnosis for Precision Prevention-2 (DETECT-2): protocol for a two-arm equivalence UK multi-centre randomised controlled trial evaluating uptake of genetic testing
Auhtors: Caitlin T. Fierheller, Priyanka Deshmukh, Ashwin Kalra, Hamda Mohamed, Wythehi Ambihapathy, Dona Chakraborty, Michail Sideris, Amanda Dibden, Lucy Mitchinson, Bhagyashree Ingle, Yuxiao Sun, Grace Norman, Rosie Corbie, Rhian Gabe, Kevin Monahan, Angela F. Brady, Jonathan Crook, Samantha Quaife, Shibani Nicum, Fiona Walter, Emma Davidson, Nicola MacDonald, Neil Ryan, Clare Turnbull, Laura Tookman, D. Gareth Evans, Rosa Legood, Jo Waller, Adam Brentnall, Ranjit Manchanda
Read the Full Article on International Journal of Gynecological Cancer
Other posts featuring Ranjit Manchanda on OncoDaily.